dementia problem behaviour
Conditions
Interventions
The participants of the intervention group (MT) receive 30 minutes of
individual music therapy twice a week for 12 weeks in their own room. Patients
receive an individually tailored session in which
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Chart diagnosis of dementia Clinically relevant neuropsychiatriec symptoms
Exclusion criteria
Exclusion criteria: Never received individual music therapy and received no group music therapy during the last 3 months No major comorbid psychiater diagnosis (ie schizofrenie, psychosis, anxiety disorders). No hearing problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Well-being is measured with the Discomfort Scale - Dementia of Alzheimer Type (DS-DAT). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain will be assessed with PAIC-15. 2. The Quality of Life in Late-Stage Dementia Scale (QUALID). 3. Neuropsychiatric symptoms are assessed with the Neuropsychiatric Inventory Nursing Home Version (NPI-NH). 4. Anxiety will be derived from the NPI-NH item *anxiety*. 5. Agitation and aggression will be assessed using the caregiver-rated questionnaire Cohen-Mansfield Agitation Inventory (CMAI). 6. Symptoms of depression will be recorded using the caregiver-rated Cornell Scale for Depression in Dementia (CSDD). 7. Quality of sleep will be determined using an Actiwatch, which is a small activity monitor. It will be worn on the dominant wrist the week before the intervention started (T0) and the week directly after the last intervention session (T2). 8. Psychotropic drug use. Data on chronic and pro re nata (as needed) use will be derived from the electronic chart. Psychotropics will be categorized into antipsychotics, anxiolytics, hypnotics, antidepressants and anti-dementia drugs according to the Anatomical Therapeutic Classification (ATC) system. | — |
Countries
Netherlands
Outcome results
None listed